Sycamore Partners is finalizing a deal to acquire Walgreens Boots Alliance in a transaction valued at around $10bn, according to sources familiar with the matter. 

The acquisition, which could be announced as soon as this week, would take the struggling pharmacy giant private.

The Wall Street Journal reported that Sycamore’s offer ranges between $11.30 and $11.40 per share in cash. Walgreens shares surged as much as 8.2% following the news, closing at $10.84—up 5% for the day.

London-listed property and healthcare infrastructure firm Assura appears poised to accept a £1.61bn private equity takeover bid from KKR and Stonepeak Partners. 

The board has indicated it is “minded” to recommend the offer, should a firm bid be made at the latest proposed terms of 49.4p per share.

The latest approach marks KKR’s fifth bid for Assura, surpassing its previous offer of 48p per share in February, which valued the company at £1.56bn. The firm, which owns more than 600 buildings, including doctors’ surgeries across the UK, has been a target of multiple acquisition attempts in recent months.

Read more here.

A consortium led by Warburg Pincus and KKR & Co. is in advanced discussions to acquire German packaging firm Gerresheimer AG, positioning itself as the frontrunner after Bain Capital and other bidders exited the race, sources familiar with the matter said.

Gerresheimer, a key supplier of packaging solutions for pharmaceuticals and cosmetics, has long been a target for private equity buyout firms. The company’s market value stands at approximately €2.7bn ($2.9bn), with shares rising 11% this year. However, the Warburg Pincus-KKR consortium is reportedly not planning to offer a significant premium to its current valuation. While negotiations are progressing, a final agreement may take weeks, and the deal could still fall apart.

Read more here.